As they grapple with the economic fallout of Covid-19, about 1/3rd of U.S. states are looking for different ways to cut costs on prescription drugs including price controls. According to results from a survey on state efforts, the biggest concern for respondents is whether the price controls will hold up to legal challenges. “We may have seen more legislation enacted were it not for the Covid-19 pandemic,” said Sandy Robinson, the survey’s lead author and a managing director at Manatt Health, the health care legal and consulting arm of law firm Manatt, Phelps & Phillips LLP, which is based in Los Angeles. Read more here.
(Source: Joel Berg; MedCityNews; 11/09/20)